|
|
|
Volumn 27, Issue 1 SUPPL. 2, 2000, Pages 8-13
|
|
Ifosfamide-based drug combinations: Preclinical evaluation of drug interactions and translation into the clinic
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE DERIVATIVE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
GLUTATHIONE;
IFOSFAMIDE;
MULTIDRUG RESISTANCE PROTEIN;
PACLITAXEL;
TAXANE DERIVATIVE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOTOXICITY;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG POTENTIATION;
HUMAN;
HUMAN CELL;
NEPHROTOXICITY;
NEUROTOXICITY;
OVARY CARCINOMA;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DRUG INTERACTIONS;
DRUG SCREENING ASSAYS, ANTITUMOR;
FEMALE;
GLUTATHIONE;
HUMANS;
IFOSFAMIDE;
OVARIAN NEOPLASMS;
PACLITAXEL;
TUMOR CELLS, CULTURED;
|
|
EID: 0033976336
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (16)
|
|
References (24)
|
